Drugs / Live attenuated SA 14-14-2 vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00412516 | Dec 2006 → Mar 2010 | Japanese encephalitis | PATH | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Live attenuated SA 14-14-2 vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00412516 ↗ |
| Modality | Vaccine | “Live attenuated SA 14-14-2 vaccine” NCT00412516 ↗ |